REAL LIFE FOLLOW-UP OF PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA TREATED WITH RESLIZUMAB.
K. Liendo Martinez (Madrid, Spain), C. Correa Gutierrez (Madrid, Spain), F. De Castro Martínez (Madrid, Spain), J. Zichen (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. Garcia De Pedro (Madrid, Spain)
Source: International Congress 2022 – Severe asthma: from phenotypes to exacerbations
Session: Severe asthma: from phenotypes to exacerbations
Session type: Thematic Poster
Number: 884
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Liendo Martinez (Madrid, Spain), C. Correa Gutierrez (Madrid, Spain), F. De Castro Martínez (Madrid, Spain), J. Zichen (Madrid, Spain), L. Puente Maestu (Madrid, Spain), J. Garcia De Pedro (Madrid, Spain). REAL LIFE FOLLOW-UP OF PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA TREATED WITH RESLIZUMAB.. 884
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|